Guide for patients & caregivers

What Does an Abnormal Hydroxychloroquine Eye Test Mean?

Hydroxychloroquine eye test results explained: what OCT and visual field checks look for, what possible or definite retinopathy means and when screening starts.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does an abnormal hydroxychloroquine eye test mean?

An abnormal hydroxychloroquine eye test means a scan or vision test has shown a change in the retina that could be an early sign of damage from the medicine, called hydroxychloroquine retinopathy. In UK screening services, one abnormal test is usually reported as possible retinopathy and leads to repeat or extra tests. Two abnormal tests consistent with the medicine are reported as definite retinopathy, and the prescriber then reviews treatment with you.

This guide explains screening results for adults taking hydroxychloroquine. It cannot interpret your own scans. If a visual field test is part of your result, our guide to a visual field defect explains how field printouts are read.

Eye symptoms that need urgent care

Screening is planned and routine, but some symptoms should not wait for the next appointment. The NHS advises: "Go to A&E or call 999 if you: suddenly cannot see from 1 or both eyes; suddenly have severe eye pain."

The NHS also advises asking for an urgent GP appointment or contacting NHS 111 for changes such as blurred or double vision, flashing lights or shapes, or a dark shadow moving across your vision. The NHS hydroxychloroquine page lists vision problems such as constant blurred vision, changes to how you see colours or sensitivity to light as possible serious side effects, and advises calling NHS 111 if you think you are having a serious side effect. Outside the UK, use your local urgent care services.

Why do people on hydroxychloroquine need eye tests?

Hydroxychloroquine is used for conditions such as lupus and rheumatoid arthritis. There is a small risk that it can damage the retina, the light-sensitive layer at the back of the eye, and Arthritis UK notes that this risk rises with long-term use and higher dosage. MedlinePlus also warns that the medicine may cause serious and potentially irreversible eye problems.

A Cambridge University Hospitals leaflet explains that severe retinopathy in the central retina (the macula) causes significant, irreversible sight loss. Screening aims to find changes early, before vision is affected, so the prescriber can review treatment.

When does hydroxychloroquine eye screening start?

Timing depends on local guidance. NHS Specialist Pharmacy Service guidance, based on Royal College of Ophthalmologists recommendations, recommends an eye examination once after 5 years of treatment and then every year, or yearly from earlier if risk is increased. It lists these risk factors:

  • a very high dose of the medicine relative to body weight
  • taking tamoxifen at the same time
  • reduced kidney function (an eGFR below 60)

What do OCT, autofluorescence and visual field tests show?

Optical coherence tomography (OCT) is a painless scan that uses light to make a detailed cross-section of the layers at the back of the eye. The Cambridge leaflet notes that OCT can show changes linked to hydroxychloroquine at a very early stage, before you would notice changes to your vision. Eye drops may be used to widen the pupils, which can blur vision for several hours, so it is wise not to drive to the appointment.

The Macular Society describes fundus autofluorescence as a second scan that picks up abnormal levels of a substance called lipofuscin, which may be an early sign of disease. A visual field test checks how well you see across your field of vision. The Macular Society explains that in screening it is often done after an abnormal retinal scan, rather than as the first test. A specialised test of retinal function (multifocal electroretinography) is used only rarely.

The Cambridge leaflet says scan results are kept so they can be compared with future results, and that hospital eye screening continues every year while you take hydroxychloroquine or chloroquine. If you move area or change hospital, ask for earlier reports to be shared so the new team can compare them.

Possible or definite retinopathy: what happens next?

UK screening results are usually sent to you, your prescriber and your GP as one of three outcomes:

  • No signs of retinopathy: you are usually invited back in a year while you keep taking the medicine.
  • Possible retinopathy: one test is abnormal. You may be asked back for repeat scans or a visual field test. The Macular Society notes that treatment can usually continue at this stage because a definite diagnosis has not been made.
  • Definite retinopathy: two tests are abnormal and consistent with the medicine. The specialist who prescribes hydroxychloroquine is told and will discuss your treatment plan with you. The Macular Society describes options that depend on severity and how well the medicine is working for you.

Could something other than hydroxychloroquine explain the result?

Yes. A scan can show changes from other eye conditions, and the Macular Society notes that a visual field test or scan may be repeated after an abnormal result before any firm conclusion is drawn. The Macular Society notes that if your last screening tests were normal, new symptoms are very unlikely to be caused by hydroxychloroquine retinopathy, and other conditions such as cataracts may need checking.

SPS guidance says drivers with definite toxicity should be advised not to drive until reviewed by an ophthalmologist and should inform the DVLA. Rules differ between countries, so ask your team what applies to you.

Do not stop or change hydroxychloroquine, or its dose, because of an eye result without talking to the prescriber. The NHS advice is to keep taking your medicine unless you're advised to stop. SPS guidance places the responsibility for acting on screening results with the prescriber.

Questions to ask your clinician

These questions can help you understand an eye screening letter:

  • Is my result no signs, possible or definite retinopathy?
  • Which test was abnormal: OCT, autofluorescence or visual fields?
  • Could another eye condition explain the change?
  • When will the tests be repeated, and who will tell me the results?
  • Do I have any risk factors that mean I need screening more often?
  • Has my prescriber been sent the result, and when will we discuss it?

How SameCase can help you prepare

On SameCase, patients and verified doctors share de-identified cases. Reading how others with possible or definite retinopathy on screening discussed next steps can help you prepare questions for your eye team and prescriber. We cannot interpret your scans or advise on your treatment, and other cases may differ from yours.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning